相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB-J
Adam P. Mecca et al.
ALZHEIMERS & DEMENTIA (2022)
Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression
Klebea Carvalho et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology
Seung-Hye Lee et al.
NEURON (2021)
Avacopan for the Treatment of ANCA-Associated Vasculitis
David R. W. Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Inference and analysis of cell-cell communication using CellChat
Suoqin Jin et al.
NATURE COMMUNICATIONS (2021)
Genetic Insights into the Impact of Complement in Alzheimer's Disease
Megan Torvell et al.
GENES (2021)
Modular, efficient and constant-memory single-cell RNA-seq preprocessing
Pall Melsted et al.
NATURE BIOTECHNOLOGY (2021)
Microglia use TAM receptors to detect and engulf amyloid β plaques
Youtong Huang et al.
NATURE IMMUNOLOGY (2021)
The Impact of Complement Genes on the Risk of Late-Onset Alzheimer's Disease
Sarah M. Carpanini et al.
GENES (2021)
Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus
Brianne M. Bettcher et al.
NATURE REVIEWS NEUROLOGY (2021)
Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities
Joke Terryn et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
The Role of Complement in Synaptic Pruning and Neurodegeneration
Angela Gomez-Arboledas et al.
IMMUNOTARGETS AND THERAPY (2021)
Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets
Andrea J. Tenner
JOURNAL OF IMMUNOLOGY (2020)
Preclinical Pharmacokinetics of Complement C5a Receptor Antagonists PMX53 and PMX205 in Mice
Vinod Kumar et al.
ACS OMEGA (2020)
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease
Marti Colom-Cadena et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Shifting paradigms: The central role of microglia in Alzheimer's disease
Tina Schwabe et al.
NEUROBIOLOGY OF DISEASE (2020)
The good, the bad, and the opportunities of the complement system in neurodegenerative disease
Nicole D. Schartz et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Prosaposin and its receptors GRP37 and GPR37L1 show increased immunoreactivity in the facial nucleus following facial nerve transection
Joji Kunihiro et al.
PLOS ONE (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data
Samuel L. Wolock et al.
CELL SYSTEMS (2019)
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity
Xaria X. Li et al.
JOURNAL OF IMMUNOLOGY (2019)
The neuropathological diagnosis of Alzheimer's disease
Michael A. DeTure et al.
MOLECULAR NEURODEGENERATION (2019)
Complement dysregulation in the central nervous system during development and disease
John D. Lee et al.
SEMINARS IN IMMUNOLOGY (2019)
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model
Elizabeth Spangenberg et al.
NATURE COMMUNICATIONS (2019)
Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review
K. E. Hopperton et al.
MOLECULAR PSYCHIATRY (2018)
Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
Aleksandra Deczkowska et al.
CELL (2018)
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease
Srikant Rangaraju et al.
MOLECULAR NEURODEGENERATION (2018)
Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau
Silvia S. Kang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Inflammation: the link between comorbidities, genetics, and Alzheimer's disease
Estella A. Newcombe et al.
JOURNAL OF NEUROINFLAMMATION (2018)
The Alternative Receptor for Complement Component 5a, C5aR2, Conveys Neuroprotection in Traumatic Spinal Cord Injury
Patrick J. C. Biggins et al.
JOURNAL OF NEUROTRAUMA (2017)
Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss
Michael X. Hernandez et al.
MOLECULAR NEURODEGENERATION (2017)
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Qiaoqiao Shi et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Role of neuroinflammation in neurodegeneration: new insights
Roisin M. McManus et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis
John D. Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology
Elizabeth E. Spangenberg et al.
BRAIN (2016)
Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation
Hansen Lui et al.
CELL (2016)
TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance
Xianyuan Xiang et al.
EMBO MOLECULAR MEDICINE (2016)
Microglia Contributes to Plaque Growth by Cell Death Due to Uptake of Amyloid β in the Brain of Alzheimer's Disease Mouse Model
Sung Hoon Baik et al.
GLIA (2016)
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Yaming Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Near-optimal probabilistic RNA-seq quantification
Nicolas L. Bray et al.
NATURE BIOTECHNOLOGY (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
Periodontitis and Cognitive Decline in Alzheimer's Disease
Mark Ide et al.
PLOS ONE (2016)
Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth
Liam G. Coulthard et al.
JOURNAL OF IMMUNOLOGY (2015)
Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline
Qiaoqiao Shi et al.
JOURNAL OF NEUROSCIENCE (2015)
AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease
Tomomi Kiyota et al.
MOLECULAR THERAPY (2015)
Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Carlo Condello et al.
NATURE COMMUNICATIONS (2015)
The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory
Elodie Marciniak et al.
SCIENTIFIC REPORTS (2015)
Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis
Inge R. Holtman et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
The protective role of prosaposin and its receptors in the nervous system
Rebecca C. Meyer et al.
BRAIN RESEARCH (2014)
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
Hong Xiao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models
S. Sakura Minami et al.
NATURE MEDICINE (2014)
C1q-induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-mediated Protection against Amyloid-β Neurotoxicity
Marie E. Benoit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology
Maria I. Fonseca et al.
JOURNAL OF NEUROINFLAMMATION (2013)
PET amyloid-beta imaging in preclinical Alzheimer's disease
Andrei G. Vlassenko et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Complement Protein C1q Directs Macrophage Polarization and Limits Inflammasome Activity during the Uptake of Apoptotic Cells
Marie E. Benoit et al.
JOURNAL OF IMMUNOLOGY (2012)
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Dorothy P. Schafer et al.
NEURON (2012)
Inflammation in Alzheimer Disease-A Brief Review of the Basic Science and Clinical Literature
Tony Wyss-Coray et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
CD45 Deficiency Drives Amyloid-β Peptide Oligomers and Neuronal Loss in Alzheimer's Disease Mice
Yuyan Zhu et al.
JOURNAL OF NEUROSCIENCE (2011)
Inhibiting the C5-C5a receptor axis
Trent M. Woodruff et al.
MOLECULAR IMMUNOLOGY (2011)
Microglial C5aR (CD88) expression correlates with amyloid-β deposition in murine models of Alzheimer's disease
Rahasson R. Ager et al.
JOURNAL OF NEUROCHEMISTRY (2010)
The Role of the Complement System and the Activation Fragment C5a in the Central Nervous System
Trent M. Woodruff et al.
NEUROMOLECULAR MEDICINE (2010)
Prosaposin Deficiency and Saposin B Deficiency (Activator-Deficient Metachromatic Leukodystrophy): Report on Two Patients Detected by Analysis of Urinary Sphingolipids and Carrying Novel PSAP Gene Mutations
Ladislav Kuchar et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
John C. Morris et al.
ARCHIVES OF NEUROLOGY (2009)
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease
Maria I. Fonseca et al.
JOURNAL OF IMMUNOLOGY (2009)
CD74 interacts with APP and suppresses the production of Aβ
Shuji Matsuda et al.
MOLECULAR NEURODEGENERATION (2009)
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease
Jun Zhou et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The classical complement cascade mediates CNS synapse elimination
Beth Stevens et al.
CELL (2007)
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease
TM Woodruff et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease
MI Fonseca et al.
JOURNAL OF NEUROSCIENCE (2004)
Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation
IH Cheng et al.
NATURE MEDICINE (2004)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation
H Hulková et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
